Skip to main content

Table 2 Participants characteristics and risk factor analysis between patients on corticosteroid therapy (POCT) and controls (CONT)

From: Molecular characterization and risk analysis of Giardia duodenalis assemblages in corticosteroid-treated and non-treated patients in Ismailia, Arab Republic of Egypt

Variable

Categories

Total (N = 52)

POCT (N = 21)

CONT (N = 31)

OR

95% CI

p-value

N

%

N

%

N

%

 

Sex

Male

31

59.6

8

38.1

23

74.2

0.2

0.1–0.8

0.009

Female

21

40.4

13

61.9

8

25.8

Ref

  

Mean age in years (SD)

12.3 (16.7)

21.7 (23.4)

5.8 (1.9)

1.5

1.1–2.1

0.006

 Residence

Urban

14

26.9

0

0.0

14

45.2

NC

 

Rural

38

73.1

21

100.0

17

54.8

Ref

 

 Symptomatic

Yes

25

48.1

9

42.9

16

51.6

0.7

0.2–2.5

0.535

No

27

51.9

12

57.14

15

48.4

Ref

  

 Abdominal pain

Yes

18

72.0

6

28.6

12

38.7

0.7

0.1–6.2

0.673

No

7

28.0

3

14.3

4

12.9

Ref

  

 Diarrhoea

Yes

10

40.0

6

28.6

4

12.9

6.0

0.8–52.6

0.087

No

15

60.0

3

14.3

12

38.7

Ref

  

 Other symptoms*

Yes

10

40.0

9

42.9

1

3.2

NC

  

No

15

60.0

0

0.0

15

48.4

Ref

  

 Owns domestic animals

Yes

21

40.4

6

28.6

15

48.4

0.4

0.1–1.6

0.153

No

31

59.6

15

71.4

16

51.6

Ref

  

 Has access to potable water

Yes

45

86.5

21

100.0

24

77.4

NC

  

No

7

13.5

0

0.0

7

22.6

Ref

  

 Has access to sewage system

Yes

39

75.0

15

71.4

24

77.4

0.7

0.2–3.2

0.625

No

13

25.0

6

28.6

7

22.6

Ref

  

 Concomitant parasitic infection

Yes

17

32.7

15

71.4

2

6.5

36.3

5.6–367.7

 < 0.001

No

35

67.3

6

28.6

29

93.5

Ref

  
  1. *Other symptoms refer to epigastric pain, postprandial heartburn, constipation, loss of weight, nausea, and pallor
  2. Bold numbers reflect statistically significant association
  3. OR Odds ratio, CI Confidence interval, Ref Reference category, SD Standard deviation, POCT Patients on corticosteroid therapy, CONT Controls, NC Not calculable (Zero observations in cells)